David Laskow-Pooley

David Laskow-Pooley is an experienced entrepreneur and investor with a diverse background in the pharmaceutical and biotechnology sectors. Currently serving as Founder, Investor, and Director at LRE System Ltd, and holding notable positions as Non-Executive Chairman at NeuroVive Pharmaceutical AB and Oxford Silk Phage Technologies Ltd, as well as Non-Executive Director at Marker Therapeutics, Inc. David also manages Pharmafor Ltd, providing business implementation services to emerging companies. Previously, David held the role of CEO at London Pharma, leading the repurposing of a malaria drug for oncology. With a BSc in Pharmacy from Sunderland School of Pharmacy, David has demonstrated a commitment to addressing challenges in healthcare through innovative business models and strategic leadership.